Underlying reasons for post-mortem diagnosed lung cancer cases – A robust retrospective comparative study from Hungary (HULC study)

Bibliographic Details
Title: Underlying reasons for post-mortem diagnosed lung cancer cases – A robust retrospective comparative study from Hungary (HULC study)
Authors: Zolta´n Kiss, Krisztina Bogos, Lilla Tamási, Gyula Ostoros, Veronika Müller, Nóra Bittner, Veronika Sárosi, Aladár Vastag, Kata Knollmajer, Máté Várnai, Krisztina Kovács, Andrea Berta, István Köveskuti, Eugenia Karamousouli, György Rokszin, Zsolt Abonyi-Tóth, Zsófia Barcza, István Kenessey, András Weber, Péter Nagy, Petra Freyler-Fadgyas, Miklós Szócska, Péter Szegner, Lászlóné Hilbert, Gabriella Branyiczkiné Géczy, György Surján, Judit Moldvay, Zoltán Vokó, Gabriella Gálffy, Zoltán Polányi
Source: Frontiers in Oncology, Vol 12 (2022)
Publisher Information: Frontiers Media S.A., 2022.
Publication Year: 2022
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: lung cancer, post-mortem diagnoses, late stage, lung cancer mortality, delayed diagnosis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: ObjectiveThe Hungarian Undiagnosed Lung Cancer (HULC) study aimed to explore the potential reasons for missed LC (lung cancer) diagnosis by comparing healthcare and socio-economic data among patients with post-mortem diagnosed LC with those who were diagnosed with LC during their lives.MethodsThis nationwide, retrospective study used the databases of the Hungarian Central Statistical Office (HCSO) and National Health Insurance Fund (NHIF) to identify patients who died between January 1, 2019 and December 31, 2019 and were diagnosed with lung cancer post-mortem (population A) or during their lifetime (population B). Patient characteristics, socio-economic factors, and healthcare resource utilization (HCRU) data were compared between the diagnosed and undiagnosed patient population.ResultsDuring the study period, 8,435 patients were identified from the HCSO database with LC as the cause of death, of whom 1,203 (14.24%) had no LC-related ICD (International Classification of Diseases) code records in the NHIF database during their lives (post-mortem diagnosed LC population). Post-mortem diagnosed LC patients were significantly older than patients diagnosed while still alive (mean age 71.20 vs. 68.69 years, p
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2234-943X
Relation: https://www.frontiersin.org/articles/10.3389/fonc.2022.1032366/full; https://doaj.org/toc/2234-943X
DOI: 10.3389/fonc.2022.1032366
Access URL: https://doaj.org/article/dc1a39dc32514d11b8d8fffbd26a0f45
Accession Number: edsdoj.1a39dc32514d11b8d8fffbd26a0f45
Database: Directory of Open Access Journals
More Details
ISSN:2234943X
DOI:10.3389/fonc.2022.1032366
Published in:Frontiers in Oncology
Language:English